NNM Securities

COMPANY
more from company profile
HomeMarket Info Company Profile Smart Quotes

Smart Quotes

MEDICAMEN BIOTECH LTD.

NSE : MEDICAMEQBSE : 531146ISIN CODE : INE646B01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE541.652.85 (+0.53 %)
PREV CLOSE ( ) 538.80
OPEN PRICE ( ) 551.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4358
TODAY'S LOW / HIGH ( )519.00 563.65
52 WK LOW / HIGH ( )356.75 903.5
NSE541.850.65 (+0.12 %)
PREV CLOSE( ) 541.20
OPEN PRICE ( ) 560.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 20478
TODAY'S LOW / HIGH( ) 519.00 568.95
52 WK LOW / HIGH ( )355.45 845
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1993
Management Info
Rahul Bishnoi - Chairman - Managing Director
Registered Office

Address 1506,Chiranjiv Tower,43, Nehru Place,
New Delhi,
Delhi-110019

Phone 011-47589500-51

Email info@medicamen.com

Website www.medicamen.com

Registrars Details
Link Intime India Pvt Ltd.
Noble Heights, 1st Floor, Plot NH 2,C-1 Block LSC, Near Savitri Market,Janakpuri,New Delhi
 Listing : BSE, NSE
NEWS
23Mar Medicamen Biotech informs about disclo
Medicamen Biotech has informed that it enclosed disclosure under regulat..
23Mar Medicamen Biotech informs about disclo
Medicamen Biotech has enclosed the disclosure under Regulation 29(2) of..
16Mar Medicamen Biotech informs about disclo
Medicamen Biotech has attached disclosure dated March 16, 2024 in Form-D..
08Mar Medicamen Biotech informs about disclo
Medicamen Biotech has informed that it attached disclosure dated March 0..
03Oct Medicamen Biotech informs about closur
In terms of the provisions of the Code of Conduct to Regulate, Monitor a..
MORE
Financials
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit27.66150.01
Gross Profit 40.09 173.32
Operating Profit 64.15266.09
Net Sales 442.041378.84
MORE
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Alkem Laboratories (BSE)
 5148.30 (5.08%)
M.Cap (Rs. in Cr)61555.65
Fredun Pharma (BSE)
 981.65 (8.95%)
M.Cap (Rs. in Cr)463.50
Pfizer (BSE)
 4258.40 (1.10%)
M.Cap (Rs. in Cr)19481.21
Ajanta Pharma (BSE)
 2415.05 (1.60%)
M.Cap (Rs. in Cr)30409.50
Lupin (BSE)
 1679.75 (1.48%)
M.Cap (Rs. in Cr)76554.62
MORE
Shareholding Pattern
NON-INSTITUTION 55.69%
PROMOTERS 43.21%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
MORE
Mf Holdings
Scheme NameHold(%)
Motilal Oswal S&P B...0.02
MORE
ATTENTION INVESTORSKYCIPO
TERMS & CONDITIONS| PRIVACY POLICY| REFUND & CANCELLATION POLICY| DISCLAIMER| DISCLOSURE| KMP DETAILS | CDSL e-Voting | SEBI| FMC| NSE| BSE| MCX | SCORES
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
Assamese Bengali Gujrati Hindi Kanada
Kashmiri Konkani Malyalam Marathi Oriya
Punjabi Sindhi Tamil Telegu Urdu
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
SMART ODR Portal

Notices/Communique Links

BSE | NSE | MCX | CDSL
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.